Source: Pharmaceutical Processing

Igenica: Pierre Fabre Acquires Immunotherapies from Igenica Biotherapeutics

NewsPierre Fabre Pharmaceuticals acquires promising assets from Igenica Biotherapeutics in the field of immuno-oncology.Contributed Author: BusinessWireTopics: Operations

Read full article »
Igenica's Competitors | Igenica's News | Igenica's Financials
Stay up-to-date with the latest news on Igenica
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Robert Schreiber's photo - Co-Founder of Igenica

Co-Founder

Robert Schreiber

CEO Approval Rating

78/100

Read more
Stay up-to-date with the latest news on Igenica